June 25, 2020
Robbins Geller Rudman & Dowd LLP will represent a proposed class of shareholders in a suit in New York federal court accusing pharmaceutical maker Mallinckrodt PLC of misrepresenting prospects for a drug it developed, a judge said Thursday.